New Drugs Alexion Receives FDA Approval of Soliris (eculizumab) for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder 6 years ago
Pharma Industry News Pharma frustration mounts as Johnson toys with no-deal Brexit pronouncements 6 years ago
Pharma Industry News FDA clears Dupixent as first-ever drug for chronic rhinosinusitis with nasal polyps 6 years ago